Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The Blockchain Association, a lobbying group for encryption, has filed a lawsuit against the U.S. Internal Revenue Service's regulation on "DeFi brokers"

The Blockchain Association, a lobbying group for encryption, has filed a lawsuit against the U.S. Internal Revenue Service's regulation on "DeFi brokers"

Bitget2024/12/28 20:41

On December 28, the crypto lobbying group Blockchain Association stated that it has filed a lawsuit against the new "broker" related regulations passed by the U.S. Internal Revenue Service and Department of Treasury. The U.S. tax agency and treasury have overstepped their legal authority, violated the Administrative Procedure Act, and are unconstitutional. They expanded the definition of "broker", including providers at the front end of DeFi transactions even though they do not execute transactions. This not only infringes on the privacy rights of individuals using decentralized technology but will also push this burgeoning technology overseas, stifling innovation and burdening American entrepreneurs.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss